Two-Year Outcome of Patients Treated With Sirolimus- Versus Paclitaxel-Eluting Stents in an Unselected Population With Coronary Artery Disease (from the REWARDS Registry)

American Journal of Cardiology

Volumn 102, Issue 3, 2008, Pages 292-297

  Roy, Probal ^a   Bonello, Laurent ^a   de Labriolle, Axel ^a   Okabe, Teruo ^a   Pinto Slottow, Tina L ^a   Steinberg, Daniel H ^a   Torguson, Rebecca ^a   Smith, Kimberly ^a   Xue, Zhenyi ^a   Satler, Lowell F ^a   Kent, Kenneth M ^a   Suddath, William O ^a   Pichard, Augusto D ^a   Waksman, Ron ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HIRULOG; PACLITAXEL; RAPAMYCIN;

ADULT; ADVERSE OUTCOME; ARTICLE; CONFIDENCE INTERVAL; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; DISEASE REGISTRY; DRUG EFFICACY; DRUG ELUTING STENT; DRUG SAFETY; DYSLIPIDEMIA; FEMALE; FOLLOW UP; HAZARD RATIO; HEART INFARCTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVASCULARIZATION; THROMBOSIS; UNSTABLE ANGINA PECTORIS;

AGED; CORONARY DISEASE; CORONARY THROMBOSIS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PACLITAXEL; SIROLIMUS; TREATMENT OUTCOME;

EID: 46649088202     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.03.053     Document Type: Article

References (24)

1. Moses J.W., Leon M.B., Popma J.J., Fitzgerald P.J., Holmes D.R., O'Shaughnessy C., Caputo R.P., Kereiakes D.J., Williams D.O., Teirstein P.S., Jaeger J.L., Kuntz R.E., and SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323
2. Stone G.W., Ellis S.G., Cox D.A., Hermiller J., O'Shaughnessy C., Mann J.T., Turco M., Caputo R., Bergin P., Greenberg J., Popma J.J., Russell M.E., and TAXUS-IV Investigators. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350 (2004) 221-231
3. Morice M.C., Colombo A., Meier B., Serruys P., Tamburino C., Guagliumi G., Sousa E., Stoll H.P., and REALITY Trial Investigators. Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: A randomized controlled trial. JAMA 295 (2006) 895-904
4. Ong A.T., Serruys P.W., Aoki J., Hoye A., van Mieghem C.A., Rodriguez-Granillo G.A., Valgimigli M., Sonnenschein K., Regar E., van der Ent M., de Jaegere P.P., McFadden E.P., et al. The unrestricted use of paclitaxel- versus sirolimus-eluting stents for coronary artery disease in an unselected population: one-year results of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registry. J Am Coll Cardiol 45 (2005) 1135-1141
5. Williams D.O., Abbott J.D., Kip K.E., and DEScover Investigators. Outcomes of 6906 patients undergoing percutaneous coronary intervention in the era of drug-eluting stents: report of the DEScover Registry. Circulation 114 (2006) 2154-2162
6. Windecker S., Remondino A., Eberli F.R., Juni P., Raber L., Wenaweser P., Togni M., Billinger M., Tuller D., Seiler C., Roffi M., Corti R., et al. Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. N Engl J Med 353 (2005) 653-662
7. Dibra A., Kastrati A., Mehilli J., Pache J., Schuhlen H., von Beckerath N., Ulm K., Wessely R., Dirschinger J., Schomig A., and ISAR-DIABETES Study Investigators. Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients. N Engl J Med 353 (2005) 663-670
8. Kastrati A., Mehilli J., von Beckerath N., Dibra A., Hausleiter J., Pache J., Schuhlen H., Schmitt C., Dirschinger J., Schomig A., and ISAR-DESIRE Study Investigators. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial. JAMA 293 (2005) 165-171
9. Mehilli J., Dibra A., Kastrati A., Pache J., Dirschinger J., Schömig A., and Intracoronary Drug-Eluting Stenting to Abrogate Restenosis in Small Arteries (ISAR-SMART 3) Study Investigators. Randomized trial of paclitaxel- and sirolimus-eluting stents in small coronary vessels. Eur Heart J 27 (2006) 260-266
10. Kim Y.H., Park S.W., Lee S.W., Park D.W., Yun S.C., Lee C.W., Hong M.K., Kim H.S., Ko J.K., Park J.H., Lee J.H., Choi S.W., et al., Long-DES-II Study Investigators. Sirolimus-eluting stent versus paclitaxel-eluting stent for patients with long coronary artery disease. Circulation 114 (2006) 2148-2153
11. Kastrati A., Dibra A., Eberle S., Mehilli J., Suarez de Lezo J., Goy J.J., Ulm K., and Schomig A. Sirolimus-eluting stents vs paclitaxel-eluting stents in patients with coronary artery disease: meta-analysis of randomized trials artery disease: meta-analysis of randomized trials. JAMA 294 (2005) 819-825
12. Roiron C., Sanchez P., Bouzamondo A., Lechat P., and Montalescot G. Drug eluting stents: an updated meta-analysis of randomised controlled trials. Heart 92 (2006) 641-649
13. Biondi-Zoccai G.G., Lotrionte M., Abbate A., Valgimigli M., Testa L., Burzotta F., Crea F., and Agostoni P. Direct and indirect comparison meta-analysis demonstrates the superiority of sirolimus- versus paclitaxel-eluting stents across 5854 patients. Int J Cardiol 114 (2007) 104-105
14. Schömig A., Dibra A., Windecker S., Mehilli J., Suárez de Lezo J., Kaiser C., Park S.J., Goy J.J., Lee J.H., Di Lorenzo E., Wu J., Jüni P., Pfisterer M.E., Meier B., and Kastrati A. A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease. J Am Coll Cardiol 50 (2007) 1373-1380
15. Camenzind E., Steg P.G., and Wijns W. Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern. Circulation 115 (2007) 1440-1455
16. Pfisterer M., Brunner-La Rocca H., Buser P., Rickenbacher P., Hunziker P., Mueller C., Jeger R., Bader F., Osswald S., Kaiser C., and BASKET-LATE Investigators. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 48 (2006) 2584-2591
17. Mauri L., Hsieh W.H., Massaro J.M., Ho K.K., D'Agostino R., and Cutlip D.E. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 356 (2007) 1020-1029
18. Spaulding C., Daemen J., Boersma E., Cutlip D.E., and Serruys P.W. A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 356 (2007) 989-997
19. Stone G.W., Moses J.W., Ellis S.G., Schofer J., Dawkins K.D., Morice M.C., Colombo A., Schampaert E., Grube E., Kirtane A.J., Cutlip D.E., Fahy M., et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 356 (2007) 998-1008
20. Kastrati A., Mehilli J., Pache J., Kaiser C., Valgimigli M., Kelbaek H., Menichelli M., Sabaté M., Suttorp M.J., Baumgart D., Seyfarth M., Pfisterer M.E., et al. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 356 (2007) 1030-1039
21. Pan M., Suárez de Lezo J., Medina A., Romero M., Delgado A., Segura J., Ojeda S., Mazuelos F., Hernandez E., Melian F., Pavlovic D., Esteban F., et al. Drug-eluting stents for the treatment of bifurcation lesions: a randomized comparison between paclitaxel and sirolimus stents. Am Heart J 153 (2007) 15.e1-15.e7
22. Cervinka P., Costa M.A., Angiolillo D.J., Spacek R., Bystron M., Kvasnák M., Veselka J., Nanda H., Futamatsu H., and Futamatsu K. Head-to-head comparison between sirolimus-eluting and paclitaxel-eluting stents in patients with complex coronary artery disease: an intravascular ultrasound study. Catheter Cardiovasc Interv 67 (2006) 846-851
23. Berger A., Stauffer J.C., Seydoux C., Siegenthaler M., Benoît A., and Goy J.J. Three-year follow-up of the first prospective randomized comparison between paclitaxel and sirolimus stents: the TAXi-LATE trial. Catheter Cardiovasc Interv 70 (2007) 163-166
24. Javaid A., Chu W.W., Cheneau E., Clavijo L.C., Satler L.F., Kent K.M., Weissman N.J., Pichard A.D., and Waksman R. Comparison of paclitaxel-eluting stent and sirolimus-eluting stent expansion at incremental delivery pressures. Cardiovasc Revasc Med 7 (2006) 208-211